PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
32199135-8	2020	Methanone 16 and its carbamate derivative 17b inhibit FLT3-ITD at least as potently as the TKi AC220 (quizartinib).	Carbamates	21-30	fms related receptor tyrosine kinase 3	Homo sapiens	54-58	
23618709-4	2013	Structure-activity relationships led to the discovery of sulfonamide, carbamate and urea series of FLT3 inhibitors.	Carbamates	70-79	fms related receptor tyrosine kinase 3	Homo sapiens	99-103	
23618709-5	2013	Previous studies showed that the sulfonamide 4 and carbamate 5 series were potent and selective FLT3 inhibitors with good in vivo efficacy.	Carbamates	51-60	fms related receptor tyrosine kinase 3	Homo sapiens	96-100	
22726931-2	2012	The structure-activity relationships led to the discovery of two carbamate series, and some potent compounds within these two series exhibited better growth inhibition of FLT3-mutated MOLM-13 cells than FLT3 inhibitors sorafenib (2) and ABT-869 (3).	Carbamates	65-74	fms related receptor tyrosine kinase 3	Homo sapiens	171-175	
22726931-2	2012	The structure-activity relationships led to the discovery of two carbamate series, and some potent compounds within these two series exhibited better growth inhibition of FLT3-mutated MOLM-13 cells than FLT3 inhibitors sorafenib (2) and ABT-869 (3).	Carbamates	65-74	fms related receptor tyrosine kinase 3	Homo sapiens	203-207